Candriam S.C.A. Global Blood Therapeutics, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$32.4 - $68.18 $13.6 Million - $28.5 Million	-418,735 Reduced 53.71%	360,956 $24.6 Million
Q2 2022 Aug 03, 2022	BUY	$22.3 - $37.39 $512,520 - $859,334	22,983 Added 3.04%	779,691 $24.9 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $2.78 Million - $3.86 Million	108,369 Added 16.71%	756,708 $26.2 Million
Q4 2021 Feb 10, 2022	BUY	$24.9 - $40.26 $7.83 Million - $12.7 Million	314,298 Added 94.09%	648,339 $19 Million
Q3 2021 Nov 09, 2021	BUY	$25.48 - $37.34 $3.51 Million - $5.14 Million	137,711 Added 70.14%	334,041 $8.51 Million
Q2 2021 Jul 20, 2021	BUY	$32.46 - $43.42 $6.37 Million - $8.52 Million	196,330 New	196,330 $6.88 Million
Q3 2020 Oct 19, 2020	SELL	$52.76 - $74.49 $3.58 Million - $5.05 Million	-67,843 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$48.73 - $81.82 $1.11 Million - $1.87 Million	22,843 Added 50.76%	67,843 $4.28 Million
Q4 2019 Jan 21, 2020	BUY	$45.7 - $81.86 $2.06 Million - $3.68 Million	45,000 New	45,000 $4,000
Q1 2019 May 02, 2019	SELL	$39.99 - $53.48 $3.84 Million - $5.13 Million	-96,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $2.14 Million - $3.17 Million	-68,000 Reduced 41.46%	96,000 $3.94 Million
Q3 2018 Nov 07, 2018	BUY	$38.0 - $51.1 $2.77 Million - $3.73 Million	73,000 Added 80.22%	164,000 $6.23 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $541,800 - $702,100	14,000 Added 18.18%	91,000 $4.11 Million
Q1 2018 May 09, 2018	SELL	$39.6 - $65.9 $1.19 Million - $1.98 Million	-30,000 Reduced 28.04%	77,000 $3.72 Million
Q4 2017 Feb 07, 2018	BUY	$29.7 - $45.7 $297,000 - $457,000	10,000 Added 10.31%	107,000 $4.21 Million
Q3 2017 Nov 03, 2017	BUY	$25.1 - $31.05 $2.43 Million - $3.01 Million	97,000	97,000 $3.01 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account